1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Switzerland >
  5. Merz Pharma & Co. KGaA Acquires Neocutis S.A.

M&A Deal Summary

Merz Pharma & Co. KGaA Acquires Neocutis S.A.

On July 31, 2013, Merz Pharma & Co. KGaA acquired consumer products company Neocutis S.A.

Acquisition Highlights
  • This is Merz Pharma & Co. KGaA’s 1st transaction in the Consumer Products sector.
  • This is Merz Pharma & Co. KGaA’s 1st transaction in Switzerland.

M&A Deal Summary
Date 2013-07-31
Target Neocutis S.A.
Sector Consumer Products
Buyer(s) Merz Pharma & Co. KGaA
Deal Type Add-on Acquisition

Target

Neocutis S.A.

Pully, Switzerland
Neocutis S.A. is a developer and distributor of innovative cosmetic products for dermatologic conditions and anti-aging skincare.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Merz Pharma & Co. KGaA

Frankfurt am Main, Germany
Category Company
Sector Life Science
Revenue 980M USD (2012)
DESCRIPTION

Merz Pharma GmbH & Co. KGaA combines the activities of its three subsidiaries, namely Merz Pharmaceuticals, Merz Consumer Care, and Merz Dental.

DEAL STATS #
Overall 3 of 6
Sector: Consumer Products M&A 1 of 1
Type: Add-on Acquisition M&A Deals 2 of 5
Country: Switzerland M&A 1 of 2
Year: 2013 M&A 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-07-19 Lasya - Intellectual Property Assets

Carrboro, North Carolina, United States

Lasya, Inc. - Intellectual Property Assets includes both U.S. and international patent filings of deoxyArbutin.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-11-11 Anteis S.A.

Meyrin, Switzerland

Anteis S.A. is specializes in the development, manufacture and commercialization of medical devices in the area of aesthetics.

Buy -
Mergr

Solution for

Product

Company

Legal